25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Bayer AG NA
Buy, Hold or Sell?

Let's analyze Bayer together

I guess you are interested in Bayer AG NA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bayer AG NA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bayer AG NA

I send you an email if I find something interesting about Bayer AG NA.

1. Quick Overview

1.1. Quick analysis of Bayer (30 sec.)










1.2. What can you expect buying and holding a share of Bayer? (30 sec.)

How much money do you get?

How much money do you get?
€0.14
When do you have the money?
1 year
How often do you get paid?
93.5%

What is your share worth?

Current worth
€36.49
Expected worth in 1 year
€35.19
How sure are you?
64.5%

+ What do you gain per year?

Total Gains per Share
€-1.17
Return On Investment
-5.8%

For what price can you sell your share?

Current Price per Share
€20.19
Expected price per share
€0 - €25.38
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bayer (5 min.)




Live pricePrice per Share (EOD)
€20.19
Intrinsic Value Per Share
€38.10 - €44.45
Total Value Per Share
€74.59 - €80.94

2.2. Growth of Bayer (5 min.)




Is Bayer growing?

Current yearPrevious yearGrowGrow %
How rich?$37.6b$41.6b-$5.3b-14.7%

How much money is Bayer making?

Current yearPrevious yearGrowGrow %
Making money-$332.2m$380m-$712.3m-214.4%
Net Profit Margin-4.7%2.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Bayer (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bayer?

Welcome investor! Bayer's management wants to use your money to grow the business. In return you get a share of Bayer.

First you should know what it really means to hold a share of Bayer. And how you can make/lose money.

Speculation

The Price per Share of Bayer is €20.19. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bayer.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bayer, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €36.49. Based on the TTM, the Book Value Change Per Share is €-0.32 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.27 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.03 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bayer.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.04-0.2%-0.34-1.7%-0.70-3.5%-0.42-2.1%0.090.4%
Usd Book Value Change Per Share0.090.5%-0.34-1.7%-0.29-1.4%-0.49-2.4%1.246.1%
Usd Dividend Per Share0.120.6%0.040.2%1.276.3%1.195.9%1.296.4%
Usd Total Gains Per Share0.211.0%-0.31-1.5%0.984.8%0.703.5%2.5312.5%
Usd Price Per Share27.63-35.15-53.94-53.29-67.63-
Price to Earnings Ratio-190.09--45.71-6.66-0.84-11.83-
Price-to-Total Gains Ratio130.57-13.89--6.09-13.36-8.20-
Price to Book Ratio0.72-0.96-1.28-1.35-2.01-
Price-to-Total Gains Ratio130.57-13.89--6.09-13.36-8.20-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share21.1922315
Number of shares47
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.041.19
Usd Book Value Change Per Share-0.34-0.49
Usd Total Gains Per Share-0.310.70
Gains per Quarter (47 shares)-14.3832.88
Gains per Year (47 shares)-57.51131.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
17-64-68223-91122
213-128-126446-183254
320-192-184669-274386
427-257-242892-366518
533-321-3001115-457650
640-385-3581338-548782
746-449-4161560-640914
853-513-4741783-7311046
960-577-5322006-8231178
1066-641-5902229-9141310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%7.05.00.058.3%12.08.00.060.0%22.09.00.071.0%22.09.00.071.0%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%12.08.00.060.0%18.013.00.058.1%18.013.00.058.1%
Dividend per Share3.00.01.075.0%11.00.01.091.7%18.00.02.090.0%29.00.02.093.5%29.00.02.093.5%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%13.07.00.065.0%20.011.00.064.5%20.011.00.064.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bayer AG NA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.087-0.325+476%-0.275+418%-0.463+635%1.177-93%
Book Value Per Share--36.48835.177+4%40.343-10%37.807-3%36.392+0%
Current Ratio--1.2721.248+2%1.148+11%1.187+7%1.376-8%
Debt To Asset Ratio--0.7010.708-1%0.685+2%0.697+1%0.658+7%
Debt To Equity Ratio--2.3542.438-3%2.183+8%2.348+0%2.045+15%
Dividend Per Share--0.1150.034+242%1.206-90%1.129-90%1.232-91%
Eps---0.035-0.322+831%-0.666+1824%-0.404+1067%0.083-142%
Free Cash Flow Per Share--1.8141.448+25%-0.120+107%0.732+148%0.839+116%
Free Cash Flow To Equity Per Share--1.8141.448+25%-0.868+148%0.000+593896%1.341+35%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--44.455--------
Intrinsic Value_10Y_min--38.104--------
Intrinsic Value_1Y_max--3.483--------
Intrinsic Value_1Y_min--3.421--------
Intrinsic Value_3Y_max--11.206--------
Intrinsic Value_3Y_min--10.683--------
Intrinsic Value_5Y_max--19.821--------
Intrinsic Value_5Y_min--18.334--------
Market Cap19830228440.000-30%25852489717.83032886646144.950-21%50474493272.955-49%49869074165.185-48%78236205978.945-67%
Net Profit Margin---0.003-0.047+1431%0.020-115%-0.036+1091%0.018-117%
Operating Margin----0%0.133-100%0.156-100%0.160-100%
Operating Ratio--1.4011.238+13%1.307+7%1.323+6%1.283+9%
Pb Ratio0.553-30%0.7210.959-25%1.275-43%1.350-47%2.014-64%
Pe Ratio-145.811+23%-190.092-45.712-76%6.663-2953%0.841-22709%11.835-1706%
Price Per Share20.185-30%26.31533.475-21%51.378-49%50.761-48%64.418-59%
Price To Free Cash Flow Ratio2.782-30%3.6272.156+68%-23.297+742%-7.129+297%6.006-40%
Price To Total Gains Ratio100.153-30%130.56813.893+840%-6.087+105%13.365+877%8.198+1493%
Quick Ratio--0.6200.523+19%0.566+10%0.600+3%0.714-13%
Return On Assets--0.000-0.003+876%0.003-110%-0.002+521%0.003-109%
Return On Equity---0.001-0.010+977%0.008-112%-0.009+793%0.004-123%
Total Gains Per Share--0.202-0.291+245%0.931-78%0.666-70%2.410-92%
Usd Book Value--37635765300.00036282969150.000+4%41611211650.000-10%38996278215.000-3%40485668048.387-7%
Usd Book Value Change Per Share--0.091-0.341+476%-0.289+418%-0.486+635%1.236-93%
Usd Book Value Per Share--38.30936.932+4%42.356-10%39.694-3%38.208+0%
Usd Dividend Per Share--0.1210.035+242%1.266-90%1.186-90%1.294-91%
Usd Eps---0.036-0.338+831%-0.699+1824%-0.424+1067%0.087-142%
Usd Free Cash Flow--1870921800.0001493482750.000+25%-124150675.000+107%755403050.000+148%984535258.065+90%
Usd Free Cash Flow Per Share--1.9041.520+25%-0.126+107%0.769+148%0.880+116%
Usd Free Cash Flow To Equity Per Share--1.9041.520+25%-0.911+148%0.000+593896%1.408+35%
Usd Market Cap20819756839.156-30%27142528954.75034527689787.583-21%52993170487.276-49%52357540966.027-48%82140192657.294-67%
Usd Price Per Share21.192-30%27.62835.145-21%53.941-49%53.294-48%67.633-59%
Usd Profit---35696600.000-332293350.000+831%380063800.000-109%-203155650.000+469%245845938.710-115%
Usd Revenue--11700085600.00012365984675.000-5%12786207150.000-8%12039518270.000-3%11524074945.161+2%
Usd Total Gains Per Share--0.212-0.306+245%0.978-78%0.700-70%2.530-92%
 EOD+3 -5MRQTTM+28 -6YOY+15 -205Y+19 -1610Y+13 -22

3.3 Fundamental Score

Let's check the fundamental score of Bayer AG NA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-145.811
Price to Book Ratio (EOD)Between0-10.553
Net Profit Margin (MRQ)Greater than0-0.003
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.620
Current Ratio (MRQ)Greater than11.272
Debt to Asset Ratio (MRQ)Less than10.701
Debt to Equity Ratio (MRQ)Less than12.354
Return on Equity (MRQ)Greater than0.15-0.001
Return on Assets (MRQ)Greater than0.050.000
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Bayer AG NA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5022.542
Ma 20Greater thanMa 5023.645
Ma 50Greater thanMa 10026.275
Ma 100Greater thanMa 20026.692
OpenGreater thanClose20.250
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Bayer AG NA

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Fundamental data was last updated by Penke on 2024-11-09 21:40:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Bayer earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Bayer to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of -0.3% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bayer AG NA:

  • The MRQ is -0.3%. The company is not making a profit/loss.
  • The TTM is -4.7%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-0.3%TTM-4.7%+4.4%
TTM-4.7%YOY2.0%-6.7%
TTM-4.7%5Y-3.6%-1.0%
5Y-3.6%10Y1.8%-5.5%
4.3.1.2. Return on Assets

Shows how efficient Bayer is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bayer to the Drug Manufacturers - General industry mean.
  • 0.0% Return on Assets means that Bayer generated €0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bayer AG NA:

  • The MRQ is 0.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.0%TTM-0.3%+0.2%
TTM-0.3%YOY0.3%-0.6%
TTM-0.3%5Y-0.2%-0.1%
5Y-0.2%10Y0.3%-0.5%
4.3.1.3. Return on Equity

Shows how efficient Bayer is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bayer to the Drug Manufacturers - General industry mean.
  • -0.1% Return on Equity means Bayer generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bayer AG NA:

  • The MRQ is -0.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.1%TTM-1.0%+0.9%
TTM-1.0%YOY0.8%-1.8%
TTM-1.0%5Y-0.9%-0.2%
5Y-0.9%10Y0.4%-1.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bayer AG NA.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Bayer is operating .

  • Measures how much profit Bayer makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bayer to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bayer AG NA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY13.3%-13.3%
TTM-5Y15.6%-15.6%
5Y15.6%10Y16.0%-0.4%
4.3.2.2. Operating Ratio

Measures how efficient Bayer is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.40 means that the operating costs are €1.40 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Bayer AG NA:

  • The MRQ is 1.401. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.238. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.401TTM1.238+0.163
TTM1.238YOY1.307-0.068
TTM1.2385Y1.323-0.085
5Y1.32310Y1.283+0.041
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bayer AG NA.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bayer is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 1.27 means the company has €1.27 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Bayer AG NA:

  • The MRQ is 1.272. The company is just able to pay all its short-term debts.
  • The TTM is 1.248. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.272TTM1.248+0.024
TTM1.248YOY1.148+0.100
TTM1.2485Y1.187+0.061
5Y1.18710Y1.376-0.189
4.4.3.2. Quick Ratio

Measures if Bayer is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bayer to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.62 means the company can pay off €0.62 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bayer AG NA:

  • The MRQ is 0.620. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.523. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.620TTM0.523+0.098
TTM0.523YOY0.566-0.043
TTM0.5235Y0.600-0.077
5Y0.60010Y0.714-0.114
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bayer AG NA.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Bayer assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bayer to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.70 means that Bayer assets are financed with 70.1% credit (debt) and the remaining percentage (100% - 70.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bayer AG NA:

  • The MRQ is 0.701. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.708. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.701TTM0.708-0.007
TTM0.708YOY0.685+0.023
TTM0.7085Y0.697+0.011
5Y0.69710Y0.658+0.039
4.5.4.2. Debt to Equity Ratio

Measures if Bayer is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bayer to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 235.4% means that company has €2.35 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bayer AG NA:

  • The MRQ is 2.354. The company is just not able to pay all its debts with equity.
  • The TTM is 2.438. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.354TTM2.438-0.083
TTM2.438YOY2.183+0.255
TTM2.4385Y2.348+0.089
5Y2.34810Y2.045+0.304
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Bayer generates.

  • Above 15 is considered overpriced but always compare Bayer to the Drug Manufacturers - General industry mean.
  • A PE ratio of -190.09 means the investor is paying €-190.09 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bayer AG NA:

  • The EOD is -145.811. Based on the earnings, the company is expensive. -2
  • The MRQ is -190.092. Based on the earnings, the company is expensive. -2
  • The TTM is -45.712. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-145.811MRQ-190.092+44.281
MRQ-190.092TTM-45.712-144.380
TTM-45.712YOY6.663-52.375
TTM-45.7125Y0.841-46.553
5Y0.84110Y11.835-10.994
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bayer AG NA:

  • The EOD is 2.782. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.627. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 2.156. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD2.782MRQ3.627-0.845
MRQ3.627TTM2.156+1.471
TTM2.156YOY-23.297+25.453
TTM2.1565Y-7.129+9.285
5Y-7.12910Y6.006-13.135
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Bayer is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 0.72 means the investor is paying €0.72 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Bayer AG NA:

  • The EOD is 0.553. Based on the equity, the company is cheap. +2
  • The MRQ is 0.721. Based on the equity, the company is cheap. +2
  • The TTM is 0.959. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.553MRQ0.721-0.168
MRQ0.721TTM0.959-0.237
TTM0.959YOY1.275-0.317
TTM0.9595Y1.350-0.392
5Y1.35010Y2.014-0.663
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Tax Provision  315,000-35,000280,00022,000302,000287,000589,000-660,000-71,000



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets119,859,000
Total Liabilities84,012,000
Total Stockholder Equity35,687,000
 As reported
Total Liabilities 84,012,000
Total Stockholder Equity+ 35,687,000
Total Assets = 119,859,000

Assets

Total Assets119,859,000
Total Current Assets40,144,000
Long-term Assets79,715,000
Total Current Assets
Cash And Cash Equivalents 3,888,000
Short-term Investments 6,136,000
Net Receivables 13,442,000
Inventory 13,088,000
Total Current Assets  (as reported)40,144,000
Total Current Assets  (calculated)36,554,000
+/- 3,590,000
Long-term Assets
Property Plant Equipment 13,487,000
Goodwill 32,896,000
Intangible Assets 22,985,000
Long-term Assets  (as reported)79,715,000
Long-term Assets  (calculated)69,368,000
+/- 10,347,000

Liabilities & Shareholders' Equity

Total Current Liabilities31,561,000
Long-term Liabilities52,451,000
Total Stockholder Equity35,687,000
Total Current Liabilities
Accounts payable 6,127,000
Other Current Liabilities 2,145,000
Total Current Liabilities  (as reported)31,561,000
Total Current Liabilities  (calculated)8,272,000
+/- 23,289,000
Long-term Liabilities
Long-term Liabilities Other 817,000
Long-term Liabilities  (as reported)52,451,000
Long-term Liabilities  (calculated)817,000
+/- 51,634,000
Total Stockholder Equity
Total Stockholder Equity (as reported)35,687,000
Total Stockholder Equity (calculated)0
+/- 35,687,000
Other
Capital Stock2,515,000
Common Stock Shares Outstanding 982,424
Net Invested Capital 35,687,000
Net Working Capital 8,583,000



6.3. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
82,238,000
85,054,000
82,640,000
76,710,000
75,087,000
75,394,000
136,530,000
129,454,000
126,285,000
130,203,000
128,385,000
130,763,000
126,258,000
125,474,000
123,667,000
119,520,000
117,046,000
118,777,000
114,427,000
116,549,000
120,241,000
125,782,000
128,794,000
131,010,000
124,877,000
125,052,000
121,667,000
117,242,000
116,259,000
119,881,000
119,859,000
119,859,000119,881,000116,259,000117,242,000121,667,000125,052,000124,877,000131,010,000128,794,000125,782,000120,241,000116,549,000114,427,000118,777,000117,046,000119,520,000123,667,000125,474,000126,258,000130,763,000128,385,000130,203,000126,285,000129,454,000136,530,00075,394,00075,087,00076,710,00082,640,00085,054,00082,238,000
   > Total Current Assets 
30,447,000
33,390,000
32,652,000
30,750,000
30,073,000
33,169,000
37,817,000
32,138,000
30,933,000
32,698,000
32,770,000
33,513,000
32,559,000
32,997,000
32,751,000
39,339,000
35,660,000
35,797,000
32,451,000
31,945,000
32,578,000
38,246,000
39,550,000
38,412,000
37,760,000
39,623,000
38,777,000
37,528,000
37,556,000
40,167,000
40,144,000
40,144,00040,167,00037,556,00037,528,00038,777,00039,623,00037,760,00038,412,00039,550,00038,246,00032,578,00031,945,00032,451,00035,797,00035,660,00039,339,00032,751,00032,997,00032,559,00033,513,00032,770,00032,698,00030,933,00032,138,00037,817,00033,169,00030,073,00030,750,00032,652,00033,390,00030,447,000
       Cash And Cash Equivalents 
1,899,000
2,224,000
2,773,000
5,555,000
7,581,000
5,332,000
4,981,000
4,850,000
4,052,000
4,062,000
3,343,000
4,410,000
3,185,000
2,289,000
3,148,000
5,067,000
4,191,000
5,550,000
3,389,000
4,316,000
4,564,000
5,785,000
3,412,000
4,361,000
5,171,000
4,854,000
4,481,000
6,815,000
5,907,000
4,725,000
3,888,000
3,888,0004,725,0005,907,0006,815,0004,481,0004,854,0005,171,0004,361,0003,412,0005,785,0004,564,0004,316,0003,389,0005,550,0004,191,0005,067,0003,148,0002,289,0003,185,0004,410,0003,343,0004,062,0004,052,0004,850,0004,981,0005,332,0007,581,0005,555,0002,773,0002,224,0001,899,000
       Short-term Investments 
3,525,000
6,662,000
7,233,000
6,066,000
1,517,000
7,315,000
1,556,000
1,599,000
285,000
852,000
869,000
1,144,000
2,219,000
2,762,000
2,560,000
10,473,000
7,692,000
3,762,000
3,109,000
3,903,000
3,175,000
2,409,000
4,782,000
4,713,000
4,982,000
3,121,000
3,149,000
2,491,000
4,680,000
4,197,000
6,136,000
6,136,0004,197,0004,680,0002,491,0003,149,0003,121,0004,982,0004,713,0004,782,0002,409,0003,175,0003,903,0003,109,0003,762,0007,692,00010,473,0002,560,0002,762,0002,219,0001,144,000869,000852,000285,0001,599,0001,556,0007,315,0001,517,0006,066,0007,233,0006,662,0003,525,000
       Net Receivables 
15,584,000
15,802,000
14,184,000
10,568,000
11,643,000
10,988,000
16,471,000
14,312,000
14,176,000
14,289,000
14,243,000
11,876,000
14,851,000
16,676,000
15,723,000
13,304,000
12,143,000
15,893,000
15,796,000
13,052,000
12,980,000
17,824,000
18,385,000
14,747,000
13,450,000
14,559,000
17,365,000
10,532,000
9,343,000
14,194,000
13,442,000
13,442,00014,194,0009,343,00010,532,00017,365,00014,559,00013,450,00014,747,00018,385,00017,824,00012,980,00013,052,00015,796,00015,893,00012,143,00013,304,00015,723,00016,676,00014,851,00011,876,00014,243,00014,289,00014,176,00014,312,00016,471,00010,988,00011,643,00010,568,00014,184,00015,802,00015,584,000
       Inventory 
8,408,000
8,674,000
8,459,000
6,737,000
6,550,000
6,402,000
11,089,000
11,142,000
10,961,000
10,678,000
10,391,000
10,515,000
10,770,000
10,006,000
10,128,000
10,452,000
10,961,000
10,457,000
10,125,000
10,644,000
11,314,000
10,869,000
11,371,000
12,791,000
13,636,000
13,531,000
13,768,000
13,956,000
13,929,000
13,437,000
13,088,000
13,088,00013,437,00013,929,00013,956,00013,768,00013,531,00013,636,00012,791,00011,371,00010,869,00011,314,00010,644,00010,125,00010,457,00010,961,00010,452,00010,128,00010,006,00010,770,00010,515,00010,391,00010,678,00010,961,00011,142,00011,089,0006,402,0006,550,0006,737,0008,459,0008,674,0008,408,000
       Other Current Assets 
1,031,000
28,000
3,000
1,824,000
2,782,000
3,132,000
3,720,000
235,000
794,000
232,000
1,609,000
3,250,000
1,534,000
1,264,000
1,192,000
43,000
673,000
135,000
32,000
30,000
545,000
1,359,000
1,600,000
1,800,000
521,000
0
14,000
0
0
0
0
000014,0000521,0001,800,0001,600,0001,359,000545,00030,00032,000135,000673,00043,0001,192,0001,264,0001,534,0003,250,0001,609,000232,000794,000235,0003,720,0003,132,0002,782,0001,824,0003,00028,0001,031,000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
97,505,000
95,615,000
97,250,000
93,699,000
92,477,000
90,916,000
80,181,000
81,386,000
82,980,000
81,976,000
84,604,000
87,663,000
87,536,000
89,244,000
92,598,000
87,117,000
85,429,000
82,890,000
79,714,000
78,703,000
79,714,000
79,715,000
79,715,00079,714,00078,703,00079,714,00082,890,00085,429,00087,117,00092,598,00089,244,00087,536,00087,663,00084,604,00081,976,00082,980,00081,386,00080,181,00090,916,00092,477,00093,699,00097,250,00095,615,00097,505,000000000000
       Property Plant Equipment 
13,114,000
13,085,000
12,672,000
7,405,000
7,633,000
7,330,000
13,762,000
13,938,000
12,944,000
13,934,000
13,689,000
13,072,000
12,479,000
12,103,000
11,850,000
11,502,000
11,710,000
11,810,000
11,830,000
12,036,000
12,688,000
12,786,000
13,275,000
13,921,000
13,674,000
13,312,000
13,177,000
13,449,000
13,321,000
13,472,000
13,487,000
13,487,00013,472,00013,321,00013,449,00013,177,00013,312,00013,674,00013,921,00013,275,00012,786,00012,688,00012,036,00011,830,00011,810,00011,710,00011,502,00011,850,00012,103,00012,479,00013,072,00013,689,00013,934,00012,944,00013,938,00013,762,0007,330,0007,633,0007,405,00012,672,00013,085,00013,114,000
       Goodwill 
16,312,000
16,290,000
15,823,000
14,910,000
14,751,000
14,480,000
37,770,000
37,801,000
38,146,000
38,773,000
38,368,000
39,871,000
39,126,000
39,068,000
38,466,000
35,143,000
36,080,000
37,224,000
36,965,000
39,421,000
40,106,000
39,789,000
41,583,000
43,452,000
39,648,000
39,254,000
36,922,000
33,876,000
32,299,000
32,763,000
32,896,000
32,896,00032,763,00032,299,00033,876,00036,922,00039,254,00039,648,00043,452,00041,583,00039,789,00040,106,00039,421,00036,965,00037,224,00036,080,00035,143,00038,466,00039,068,00039,126,00039,871,00038,368,00038,773,00038,146,00037,801,00037,770,00014,480,00014,751,00014,910,00015,823,00016,290,00016,312,000
       Long Term Investments 
1,753,000
1,888,000
1,950,000
5,491,000
5,275,000
4,311,000
3,316,000
3,164,000
2,680,000
2,795,000
2,856,000
2,935,000
1,984,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,984,0002,935,0002,856,0002,795,0002,680,0003,164,0003,316,0004,311,0005,275,0005,491,0001,950,0001,888,0001,753,000
       Intangible Assets 
12,915,000
13,367,000
12,685,000
11,949,000
10,747,000
11,185,000
38,312,000
37,846,000
31,503,000
36,675,000
34,904,000
35,593,000
34,709,000
34,834,000
33,722,000
25,433,000
26,029,000
26,430,000
25,308,000
24,970,000
26,258,000
26,066,000
25,367,000
25,997,000
24,183,000
23,352,000
23,438,000
23,169,000
23,363,000
23,343,000
22,985,000
22,985,00023,343,00023,363,00023,169,00023,438,00023,352,00024,183,00025,997,00025,367,00026,066,00026,258,00024,970,00025,308,00026,430,00026,029,00025,433,00033,722,00034,834,00034,709,00035,593,00034,904,00036,675,00031,503,00037,846,00038,312,00011,185,00010,747,00011,949,00012,685,00013,367,00012,915,000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
97,505,000
95,615,000
97,250,000
93,699,000
92,477,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000092,477,00093,699,00097,250,00095,615,00097,505,000000000000
> Total Liabilities 
50,341,000
49,197,000
47,157,000
39,456,000
38,226,000
37,010,000
89,311,000
79,037,000
80,137,000
82,122,000
83,438,000
84,616,000
78,741,000
76,693,000
87,801,000
88,043,000
86,347,000
84,005,000
83,849,000
85,276,000
87,073,000
88,175,000
90,590,000
89,543,000
85,951,000
84,035,000
84,543,000
83,695,000
83,181,000
84,119,000
84,012,000
84,012,00084,119,00083,181,00083,695,00084,543,00084,035,00085,951,00089,543,00090,590,00088,175,00087,073,00085,276,00083,849,00084,005,00086,347,00088,043,00087,801,00076,693,00078,741,00084,616,00083,438,00082,122,00080,137,00079,037,00089,311,00037,010,00038,226,00039,456,00047,157,00049,197,00050,341,000
   > Total Current Liabilities 
18,537,000
19,572,000
18,760,000
14,913,000
13,593,000
13,098,000
26,762,000
20,196,000
22,823,000
23,893,000
25,391,000
26,057,000
23,215,000
22,320,000
36,543,000
35,790,000
36,728,000
28,932,000
27,926,000
28,727,000
29,403,000
31,019,000
33,643,000
33,172,000
35,084,000
34,391,000
32,187,000
33,081,000
29,457,000
30,630,000
31,561,000
31,561,00030,630,00029,457,00033,081,00032,187,00034,391,00035,084,00033,172,00033,643,00031,019,00029,403,00028,727,00027,926,00028,932,00036,728,00035,790,00036,543,00022,320,00023,215,00026,057,00025,391,00023,893,00022,823,00020,196,00026,762,00013,098,00013,593,00014,913,00018,760,00019,572,00018,537,000
       Short-term Debt 
19,581,000
18,987,000
19,205,000
3,541,000
1,903,000
1,761,000
9,536,000
3,492,000
3,632,000
4,186,000
6,605,000
4,423,000
1,676,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,676,0004,423,0006,605,0004,186,0003,632,0003,492,0009,536,0001,761,0001,903,0003,541,00019,205,00018,987,00019,581,000
       Short Long Term Debt 
19,581,000
18,987,000
19,205,000
3,541,000
1,903,000
1,761,000
9,536,000
3,492,000
3,632,000
4,186,000
6,605,000
4,423,000
1,676,000
0
0
0
8,148,000
0
0
0
2,817,000
0
0
0
7,257,000
0
0
0
4,410,000
0
0
004,410,0000007,257,0000002,817,0000008,148,0000001,676,0004,423,0006,605,0004,186,0003,632,0003,492,0009,536,0001,761,0001,903,0003,541,00019,205,00018,987,00019,581,000
       Accounts payable 
6,410,000
5,690,000
5,211,000
3,928,000
5,129,000
3,943,000
4,861,000
5,281,000
5,414,000
5,507,000
5,384,000
5,697,000
6,426,000
5,331,000
5,098,000
5,461,000
5,683,000
5,190,000
5,118,000
5,587,000
6,792,000
5,847,000
6,097,000
6,549,000
7,545,000
6,268,000
5,970,000
6,500,000
7,456,000
6,398,000
6,127,000
6,127,0006,398,0007,456,0006,500,0005,970,0006,268,0007,545,0006,549,0006,097,0005,847,0006,792,0005,587,0005,118,0005,190,0005,683,0005,461,0005,098,0005,331,0006,426,0005,697,0005,384,0005,507,0005,414,0005,281,0004,861,0003,943,0005,129,0003,928,0005,211,0005,690,0006,410,000
       Other Current Liabilities 
5,105,000
9,683,000
8,512,000
7,444,000
4,263,000
7,394,000
12,365,000
11,423,000
10,582,000
7,924,000
8,795,000
7,211,000
11,418,000
13,789,000
24,073,000
22,069,000
19,902,000
18,795,000
19,100,000
18,348,000
14,715,000
19,273,000
20,973,000
21,292,000
16,105,000
2,665,000
16,257,000
2,444,000
567,000
2,224,000
2,145,000
2,145,0002,224,000567,0002,444,00016,257,0002,665,00016,105,00021,292,00020,973,00019,273,00014,715,00018,348,00019,100,00018,795,00019,902,00022,069,00024,073,00013,789,00011,418,0007,211,0008,795,0007,924,00010,582,00011,423,00012,365,0007,394,0004,263,0007,444,0008,512,0009,683,0005,105,000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
58,229,000
58,047,000
58,559,000
55,526,000
54,373,000
51,258,000
52,253,000
49,619,000
55,073,000
55,923,000
56,549,000
57,670,000
57,156,000
56,947,000
56,371,000
50,867,000
49,644,000
52,356,000
50,614,000
53,724,000
53,489,000
52,451,000
52,451,00053,489,00053,724,00050,614,00052,356,00049,644,00050,867,00056,371,00056,947,00057,156,00057,670,00056,549,00055,923,00055,073,00049,619,00052,253,00051,258,00054,373,00055,526,00058,559,00058,047,00058,229,000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
1,251,000
0
0
0
1,137,000
0
0
0
1,165,000
0
0
0
1,234,000
0
0
0
1,238,000
0
0
001,238,0000001,234,0000001,165,0000001,137,0000001,251,000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
517,000
487,000
748,000
429,000
780,000
667,000
525,000
1,234,000
1,327,000
1,357,000
1,810,000
1,838,000
1,568,000
1,784,000
1,593,000
1,065,000
987,000
1,028,000
969,000
928,000
927,000
817,000
817,000927,000928,000969,0001,028,000987,0001,065,0001,593,0001,784,0001,568,0001,838,0001,810,0001,357,0001,327,0001,234,000525,000667,000780,000429,000748,000487,000517,000000000000
       Deferred Long Term Liability 
843,000
0
0
0
1,033,000
0
0
0
5,289,000
0
0
0
5,517,000
0
0
0
4,418,000
0
0
0
4,312,000
0
0
0
3,797,000
0
0
0
0
0
0
0000003,797,0000004,312,0000004,418,0000005,517,0000005,289,0000001,033,000000843,000
> Total Stockholder Equity
30,333,000
33,617,000
32,650,000
37,196,000
36,801,000
38,328,000
47,146,000
50,245,000
45,977,000
47,910,000
44,776,000
45,965,000
47,337,000
48,609,000
35,704,000
31,327,000
30,524,000
34,588,000
30,389,000
31,103,000
33,020,000
37,437,000
38,019,000
41,272,000
38,773,000
40,864,000
36,948,000
33,380,000
32,927,000
35,605,000
35,687,000
35,687,00035,605,00032,927,00033,380,00036,948,00040,864,00038,773,00041,272,00038,019,00037,437,00033,020,00031,103,00030,389,00034,588,00030,524,00031,327,00035,704,00048,609,00047,337,00045,965,00044,776,00047,910,00045,977,00050,245,00047,146,00038,328,00036,801,00037,196,00032,650,00033,617,00030,333,000
   Common Stock
2,117,000
2,117,000
2,117,000
2,117,000
2,117,000
2,117,000
2,387,000
2,387,000
2,387,000
2,387,000
2,387,000
2,387,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
0
2,515,000
0
0
0
0
00002,515,00002,515,0002,515,0002,515,0002,515,0002,515,0002,515,0002,515,0002,515,0002,515,0002,515,0002,515,0002,515,0002,515,0002,387,0002,387,0002,387,0002,387,0002,387,0002,387,0002,117,0002,117,0002,117,0002,117,0002,117,0002,117,000
   Retained Earnings 
18,393,000
0
0
0
26,851,000
0
0
0
25,734,000
0
0
0
26,235,000
0
0
0
13,057,000
0
0
0
13,345,000
0
0
0
17,233,000
0
0
0
0
0
0
00000017,233,00000013,345,00000013,057,00000026,235,00000025,734,00000026,851,00000018,393,000
   Capital Surplus 0000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000
   Other Stockholders Equity 
9,823,000
31,500,000
30,533,000
35,079,000
7,833,000
36,211,000
44,759,000
47,858,000
17,856,000
45,523,000
42,389,000
43,578,000
18,587,000
46,094,000
33,189,000
28,812,000
14,952,000
32,073,000
27,874,000
28,588,000
17,160,000
34,922,000
35,504,000
38,757,000
19,025,000
0
34,433,000
0
0
0
0
000034,433,000019,025,00038,757,00035,504,00034,922,00017,160,00028,588,00027,874,00032,073,00014,952,00028,812,00033,189,00046,094,00018,587,00043,578,00042,389,00045,523,00017,856,00047,858,00044,759,00036,211,0007,833,00035,079,00030,533,00031,500,0009,823,000



6.4. Balance Sheets

Currency in EUR. All numbers in thousands.




6.5. Cash Flows

Currency in EUR. All numbers in thousands.




6.6. Income Statements

Currency in EUR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue47,637,000
Cost of Revenue-19,749,000
Gross Profit27,888,00027,888,000
 
Operating Income (+$)
Gross Profit27,888,000
Operating Expense-39,601,000
Operating Income8,036,000-11,713,000
 
Operating Expense (+$)
Research Development5,371,000
Selling General Administrative14,935,000
Selling And Marketing Expenses0
Operating Expense39,601,00020,306,000
 
Net Interest Income (+$)
Interest Income484,000
Interest Expense-2,047,000
Other Finance Cost-48,000
Net Interest Income-1,611,000
 
Pretax Income (+$)
Operating Income8,036,000
Net Interest Income-1,611,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,621,0008,036,000
EBIT - interestExpense = -2,047,000
-2,941,000
-894,000
Interest Expense2,047,000
Earnings Before Interest and Taxes (EBIT)0426,000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-1,621,000
Tax Provision-1,321,000
Net Income From Continuing Ops-2,942,000-2,942,000
Net Income-2,941,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net01,611,000
 

Technical Analysis of Bayer
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bayer. The general trend of Bayer is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bayer's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bayer AG NA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 25.08 < 25.35 < 25.38.

The bearish price targets are: .

Tweet this
Bayer AG NA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bayer AG NA. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bayer AG NA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bayer AG NA. The current macd is -1.76954677.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bayer price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bayer. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bayer price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Bayer AG NA Daily Moving Average Convergence/Divergence (MACD) ChartBayer AG NA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bayer AG NA. The current adx is 48.14.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bayer shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Bayer AG NA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bayer AG NA. The current sar is 21.91.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bayer AG NA Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bayer AG NA. The current rsi is 22.54. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Bayer AG NA Daily Relative Strength Index (RSI) ChartBayer AG NA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bayer AG NA. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bayer price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Bayer AG NA Daily Stochastic Oscillator ChartBayer AG NA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bayer AG NA. The current cci is -123.74717674.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Bayer AG NA Daily Commodity Channel Index (CCI) ChartBayer AG NA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bayer AG NA. The current cmo is -59.53066717.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bayer AG NA Daily Chande Momentum Oscillator (CMO) ChartBayer AG NA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bayer AG NA. The current willr is -86.86902566.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Bayer AG NA Daily Williams %R ChartBayer AG NA Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bayer AG NA.

Bayer AG NA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bayer AG NA. The current atr is 0.88680147.

Bayer AG NA Daily Average True Range (ATR) ChartBayer AG NA Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bayer AG NA. The current obv is -11,346,300.

Bayer AG NA Daily On-Balance Volume (OBV) ChartBayer AG NA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bayer AG NA. The current mfi is 14.00.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Bayer AG NA Daily Money Flow Index (MFI) ChartBayer AG NA Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bayer AG NA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-04 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-12 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-17 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-19 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-24 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-05 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-11 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-19 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-27 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-10 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-21 00:00:00MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-22 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-24 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-01 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-07 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Bayer AG NA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bayer AG NA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5022.542
Ma 20Greater thanMa 5023.645
Ma 50Greater thanMa 10026.275
Ma 100Greater thanMa 20026.692
OpenGreater thanClose20.250
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Bayer with someone you think should read this too:
  • Are you bullish or bearish on Bayer? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bayer? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bayer AG NA

I send you an email if I find something interesting about Bayer AG NA.


Comments

How you think about this?

Leave a comment

Stay informed about Bayer AG NA.

Receive notifications about Bayer AG NA in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.